Recently, the results of the 2023 "Top 20 High-tech High-growth Enterprises in Optics Valley" and "Optics Valley Rising Stars" list, which was jointly hosted by Deloitte China and the Administrative Committee of Wuhan East Lake High-tech Development Zone and aimed at discovering and commending outstanding enterprises with high-speed growth and continuous innovation in the Optics Valley area, were grandly announced. Neurophth Biotechnology Co., Ltd. (hereinafter referred to as "Neurophth"), a leading company in China specializing in gene therapy for ophthalmic diseases, announced that it was selected as an "Optics Valley Rising Star".

2023 marks the 10th anniversary of the "Optics Valley Rising Stars" selection project jointly organized by Deloitte China and the Administrative Committee of Wuhan East Lake High-tech Development Zone. This project aims to discover and commend scientific and technological innovation enterprises with high-speed growth and continuous innovation in the Optics Valley area, focus on enhancing the innovation source capability of Optics Valley, releasing innovation momentum, and promoting regional open and integrated innovation.